Silo Pharma Strengthens Intellectual Property with New Provisional Patent for PTSD TreatmentBusiness PenJanuary 22, 2025 January 22, 2025 Silo Pharma, Inc. (Nasdaq: SILO), a biopharmaceutical company focused on developing innovative therapeutics, has recently filed a provisional patent application with the U.S. Patent and...